nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—RPS6KB1—medulla oblongata—Behcet's disease	0.000776	0.00139	CbGeAlD
Bosutinib—DMPK—brain—Behcet's disease	0.000774	0.00139	CbGeAlD
Bosutinib—WEE1—brain—Behcet's disease	0.000774	0.00139	CbGeAlD
Bosutinib—CSNK1E—spinal cord—Behcet's disease	0.000769	0.00137	CbGeAlD
Bosutinib—AXL—medulla oblongata—Behcet's disease	0.000768	0.00137	CbGeAlD
Bosutinib—ERBB4—central nervous system—Behcet's disease	0.000765	0.00137	CbGeAlD
Bosutinib—EPHA2—cardiac atrium—Behcet's disease	0.000764	0.00137	CbGeAlD
Bosutinib—FYN—cardiac atrium—Behcet's disease	0.000763	0.00136	CbGeAlD
Bosutinib—BMPR2—nervous system—Behcet's disease	0.000762	0.00136	CbGeAlD
Bosutinib—ERBB3—midbrain—Behcet's disease	0.00076	0.00136	CbGeAlD
Bosutinib—MAP2K2—midbrain—Behcet's disease	0.000758	0.00136	CbGeAlD
Bosutinib—ULK3—midbrain—Behcet's disease	0.000758	0.00136	CbGeAlD
Bosutinib—SRC—skin of body—Behcet's disease	0.000758	0.00136	CbGeAlD
Bosutinib—SIK1—spinal cord—Behcet's disease	0.000757	0.00135	CbGeAlD
Bosutinib—IRAK4—spinal cord—Behcet's disease	0.000757	0.00135	CbGeAlD
Bosutinib—EPHB3—nervous system—Behcet's disease	0.000756	0.00135	CbGeAlD
Bosutinib—STK36—nervous system—Behcet's disease	0.000756	0.00135	CbGeAlD
Bosutinib—ROCK1—central nervous system—Behcet's disease	0.000755	0.00135	CbGeAlD
Bosutinib—MERTK—nervous system—Behcet's disease	0.000747	0.00134	CbGeAlD
Bosutinib—MAP3K7—midbrain—Behcet's disease	0.000746	0.00133	CbGeAlD
Bosutinib—MAP4K5—cardiac atrium—Behcet's disease	0.000745	0.00133	CbGeAlD
Bosutinib—MAP3K3—cardiac atrium—Behcet's disease	0.000745	0.00133	CbGeAlD
Bosutinib—ERBB3—spinal cord—Behcet's disease	0.000742	0.00133	CbGeAlD
Bosutinib—MAP2K2—spinal cord—Behcet's disease	0.00074	0.00132	CbGeAlD
Bosutinib—ULK3—spinal cord—Behcet's disease	0.00074	0.00132	CbGeAlD
Bosutinib—SLK—medulla oblongata—Behcet's disease	0.00074	0.00132	CbGeAlD
Bosutinib—STK25—brain—Behcet's disease	0.000739	0.00132	CbGeAlD
Bosutinib—TBK1—midbrain—Behcet's disease	0.000737	0.00132	CbGeAlD
Bosutinib—PTK2—midbrain—Behcet's disease	0.000737	0.00132	CbGeAlD
Bosutinib—EPHB4—medulla oblongata—Behcet's disease	0.000734	0.00131	CbGeAlD
Bosutinib—EPHA3—brain—Behcet's disease	0.000734	0.00131	CbGeAlD
Bosutinib—BMPR2—central nervous system—Behcet's disease	0.000733	0.00131	CbGeAlD
Bosutinib—MAP4K4—nervous system—Behcet's disease	0.000733	0.00131	CbGeAlD
Bosutinib—BCR—nervous system—Behcet's disease	0.000728	0.0013	CbGeAlD
Bosutinib—MAP3K7—spinal cord—Behcet's disease	0.000728	0.0013	CbGeAlD
Bosutinib—EPHB3—central nervous system—Behcet's disease	0.000728	0.0013	CbGeAlD
Bosutinib—STK36—central nervous system—Behcet's disease	0.000728	0.0013	CbGeAlD
Bosutinib—IRAK1—midbrain—Behcet's disease	0.000723	0.00129	CbGeAlD
Bosutinib—MAP3K12—nervous system—Behcet's disease	0.000723	0.00129	CbGeAlD
Bosutinib—TBK1—spinal cord—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—PTK2—spinal cord—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—MERTK—central nervous system—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—FYN—medulla oblongata—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—PLK2—brain—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—YES1—mammalian vulva—Behcet's disease	0.000719	0.00129	CbGeAlD
Bosutinib—SIK3—brain—Behcet's disease	0.000714	0.00128	CbGeAlD
Bosutinib—STK10—mammalian vulva—Behcet's disease	0.000712	0.00127	CbGeAlD
Bosutinib—TAOK3—mammalian vulva—Behcet's disease	0.00071	0.00127	CbGeAlD
Bosutinib—RPS6KB1—midbrain—Behcet's disease	0.000709	0.00127	CbGeAlD
Bosutinib—MAP2K1—nervous system—Behcet's disease	0.000708	0.00127	CbGeAlD
Bosutinib—STK35—nervous system—Behcet's disease	0.000708	0.00127	CbGeAlD
Bosutinib—MAP4K4—central nervous system—Behcet's disease	0.000706	0.00126	CbGeAlD
Bosutinib—CSK—nervous system—Behcet's disease	0.000703	0.00126	CbGeAlD
Bosutinib—MAP3K3—medulla oblongata—Behcet's disease	0.000703	0.00126	CbGeAlD
Bosutinib—MAP4K5—medulla oblongata—Behcet's disease	0.000703	0.00126	CbGeAlD
Bosutinib—AXL—midbrain—Behcet's disease	0.000702	0.00126	CbGeAlD
Bosutinib—BCR—central nervous system—Behcet's disease	0.000701	0.00125	CbGeAlD
Bosutinib—CSNK1A1—nervous system—Behcet's disease	0.000699	0.00125	CbGeAlD
Bosutinib—MAP3K12—central nervous system—Behcet's disease	0.000696	0.00124	CbGeAlD
Bosutinib—HCK—nervous system—Behcet's disease	0.000694	0.00124	CbGeAlD
Bosutinib—CLK1—nervous system—Behcet's disease	0.000694	0.00124	CbGeAlD
Bosutinib—PDGFRB—eye—Behcet's disease	0.000694	0.00124	CbGeAlD
Bosutinib—RPS6KB1—spinal cord—Behcet's disease	0.000692	0.00124	CbGeAlD
Bosutinib—YES1—cardiac atrium—Behcet's disease	0.000688	0.00123	CbGeAlD
Bosutinib—STK4—brain—Behcet's disease	0.000687	0.00123	CbGeAlD
Bosutinib—AXL—spinal cord—Behcet's disease	0.000685	0.00123	CbGeAlD
Bosutinib—MAP2K1—central nervous system—Behcet's disease	0.000682	0.00122	CbGeAlD
Bosutinib—STK35—central nervous system—Behcet's disease	0.000682	0.00122	CbGeAlD
Bosutinib—CAMK2G—nervous system—Behcet's disease	0.000682	0.00122	CbGeAlD
Bosutinib—BMP2K—nervous system—Behcet's disease	0.000682	0.00122	CbGeAlD
Bosutinib—CSF1R—skin of body—Behcet's disease	0.000681	0.00122	CbGeAlD
Bosutinib—TAOK3—cardiac atrium—Behcet's disease	0.00068	0.00122	CbGeAlD
Bosutinib—CAMK1D—brain—Behcet's disease	0.000679	0.00121	CbGeAlD
Bosutinib—CSK—central nervous system—Behcet's disease	0.000677	0.00121	CbGeAlD
Bosutinib—SLK—midbrain—Behcet's disease	0.000676	0.00121	CbGeAlD
Bosutinib—LRRK2—nervous system—Behcet's disease	0.000676	0.00121	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—Behcet's disease	0.000673	0.0012	CbGeAlD
Bosutinib—STK24—brain—Behcet's disease	0.000671	0.0012	CbGeAlD
Bosutinib—EPHB4—midbrain—Behcet's disease	0.000671	0.0012	CbGeAlD
Bosutinib—HCK—central nervous system—Behcet's disease	0.000669	0.0012	CbGeAlD
Bosutinib—CLK1—central nervous system—Behcet's disease	0.000669	0.0012	CbGeAlD
Bosutinib—SRC—cardiac atrium—Behcet's disease	0.000662	0.00118	CbGeAlD
Bosutinib—SLK—spinal cord—Behcet's disease	0.000659	0.00118	CbGeAlD
Bosutinib—PTK2B—nervous system—Behcet's disease	0.000658	0.00118	CbGeAlD
Bosutinib—FYN—midbrain—Behcet's disease	0.000657	0.00118	CbGeAlD
Bosutinib—CAMK2G—central nervous system—Behcet's disease	0.000656	0.00117	CbGeAlD
Bosutinib—BMP2K—central nervous system—Behcet's disease	0.000656	0.00117	CbGeAlD
Bosutinib—EPHB4—spinal cord—Behcet's disease	0.000655	0.00117	CbGeAlD
Bosutinib—LRRK2—central nervous system—Behcet's disease	0.00065	0.00116	CbGeAlD
Bosutinib—FER—brain—Behcet's disease	0.00065	0.00116	CbGeAlD
Bosutinib—TYRO3—brain—Behcet's disease	0.00065	0.00116	CbGeAlD
Bosutinib—ALK—brain—Behcet's disease	0.00065	0.00116	CbGeAlD
Bosutinib—EPHA5—brain—Behcet's disease	0.00065	0.00116	CbGeAlD
Bosutinib—YES1—medulla oblongata—Behcet's disease	0.000649	0.00116	CbGeAlD
Bosutinib—CSNK1E—nervous system—Behcet's disease	0.000648	0.00116	CbGeAlD
Bosutinib—LYN—brain—Behcet's disease	0.000646	0.00116	CbGeAlD
Bosutinib—MAP4K5—midbrain—Behcet's disease	0.000642	0.00115	CbGeAlD
Bosutinib—MAP3K3—midbrain—Behcet's disease	0.000642	0.00115	CbGeAlD
Bosutinib—FYN—spinal cord—Behcet's disease	0.000641	0.00115	CbGeAlD
Bosutinib—TAOK3—medulla oblongata—Behcet's disease	0.000641	0.00115	CbGeAlD
Bosutinib—SIK1—nervous system—Behcet's disease	0.000638	0.00114	CbGeAlD
Bosutinib—IRAK4—nervous system—Behcet's disease	0.000638	0.00114	CbGeAlD
Bosutinib—MAP4K1—brain—Behcet's disease	0.000637	0.00114	CbGeAlD
Bosutinib—MAP3K19—brain—Behcet's disease	0.000637	0.00114	CbGeAlD
Bosutinib—MAP2K5—mammalian vulva—Behcet's disease	0.000636	0.00114	CbGeAlD
Bosutinib—ABL1—brainstem—Behcet's disease	0.000635	0.00114	CbGeAlD
Bosutinib—PTK2B—central nervous system—Behcet's disease	0.000634	0.00113	CbGeAlD
Bosutinib—BTK—brain—Behcet's disease	0.000633	0.00113	CbGeAlD
Bosutinib—EPHA4—nervous system—Behcet's disease	0.000631	0.00113	CbGeAlD
Bosutinib—MAP4K5—spinal cord—Behcet's disease	0.000627	0.00112	CbGeAlD
Bosutinib—MAP3K3—spinal cord—Behcet's disease	0.000627	0.00112	CbGeAlD
Bosutinib—ERBB3—nervous system—Behcet's disease	0.000625	0.00112	CbGeAlD
Bosutinib—TNK2—brain—Behcet's disease	0.000624	0.00112	CbGeAlD
Bosutinib—CSNK1E—central nervous system—Behcet's disease	0.000624	0.00112	CbGeAlD
Bosutinib—MAP2K2—nervous system—Behcet's disease	0.000623	0.00111	CbGeAlD
Bosutinib—ULK3—nervous system—Behcet's disease	0.000623	0.00111	CbGeAlD
Bosutinib—CSF1R—mammalian vulva—Behcet's disease	0.000621	0.00111	CbGeAlD
Bosutinib—MAP3K2—nervous system—Behcet's disease	0.000619	0.00111	CbGeAlD
Bosutinib—ABL1—eye—Behcet's disease	0.000619	0.00111	CbGeAlD
Bosutinib—MAP4K2—brain—Behcet's disease	0.000616	0.0011	CbGeAlD
Bosutinib—SIK1—central nervous system—Behcet's disease	0.000614	0.0011	CbGeAlD
Bosutinib—IRAK4—central nervous system—Behcet's disease	0.000614	0.0011	CbGeAlD
Bosutinib—ABL1—retina—Behcet's disease	0.000613	0.0011	CbGeAlD
Bosutinib—MAP2K5—cardiac atrium—Behcet's disease	0.000609	0.00109	CbGeAlD
Bosutinib—EPHA4—central nervous system—Behcet's disease	0.000608	0.00109	CbGeAlD
Bosutinib—ERBB4—brain—Behcet's disease	0.000607	0.00109	CbGeAlD
Bosutinib—STK3—brain—Behcet's disease	0.000607	0.00109	CbGeAlD
Bosutinib—TBK1—nervous system—Behcet's disease	0.000606	0.00108	CbGeAlD
Bosutinib—PTK2—nervous system—Behcet's disease	0.000606	0.00108	CbGeAlD
Bosutinib—PDGFRB—skin of body—Behcet's disease	0.000604	0.00108	CbGeAlD
Bosutinib—ERBB3—central nervous system—Behcet's disease	0.000602	0.00108	CbGeAlD
Bosutinib—MAP2K2—central nervous system—Behcet's disease	0.0006	0.00107	CbGeAlD
Bosutinib—ULK3—central nervous system—Behcet's disease	0.0006	0.00107	CbGeAlD
Bosutinib—ROCK1—brain—Behcet's disease	0.000599	0.00107	CbGeAlD
Bosutinib—MAP3K2—central nervous system—Behcet's disease	0.000596	0.00107	CbGeAlD
Bosutinib—CSF1R—cardiac atrium—Behcet's disease	0.000595	0.00106	CbGeAlD
Bosutinib—YES1—midbrain—Behcet's disease	0.000593	0.00106	CbGeAlD
Bosutinib—TAOK3—midbrain—Behcet's disease	0.000586	0.00105	CbGeAlD
Bosutinib—PTK2—central nervous system—Behcet's disease	0.000584	0.00104	CbGeAlD
Bosutinib—TBK1—central nervous system—Behcet's disease	0.000584	0.00104	CbGeAlD
Bosutinib—RPS6KB1—nervous system—Behcet's disease	0.000583	0.00104	CbGeAlD
Bosutinib—BMPR2—brain—Behcet's disease	0.000582	0.00104	CbGeAlD
Bosutinib—FGR—nervous system—Behcet's disease	0.00058	0.00104	CbGeAlD
Bosutinib—YES1—spinal cord—Behcet's disease	0.000579	0.00103	CbGeAlD
Bosutinib—STK36—brain—Behcet's disease	0.000578	0.00103	CbGeAlD
Bosutinib—EPHB3—brain—Behcet's disease	0.000578	0.00103	CbGeAlD
Bosutinib—AXL—nervous system—Behcet's disease	0.000577	0.00103	CbGeAlD
Bosutinib—MAP2K5—medulla oblongata—Behcet's disease	0.000574	0.00103	CbGeAlD
Bosutinib—TAOK3—spinal cord—Behcet's disease	0.000571	0.00102	CbGeAlD
Bosutinib—MERTK—brain—Behcet's disease	0.000571	0.00102	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—Behcet's disease	0.000561	0.001	CbGeAlD
Bosutinib—CSF1R—medulla oblongata—Behcet's disease	0.00056	0.001	CbGeAlD
Bosutinib—MAP4K4—brain—Behcet's disease	0.00056	0.001	CbGeAlD
Bosutinib—FGR—central nervous system—Behcet's disease	0.000558	0.000998	CbGeAlD
Bosutinib—SRC—spinal cord—Behcet's disease	0.000557	0.000996	CbGeAlD
Bosutinib—BCR—brain—Behcet's disease	0.000556	0.000995	CbGeAlD
Bosutinib—NUAK2—brain—Behcet's disease	0.000556	0.000995	CbGeAlD
Bosutinib—AXL—central nervous system—Behcet's disease	0.000556	0.000994	CbGeAlD
Bosutinib—MAP3K12—brain—Behcet's disease	0.000552	0.000988	CbGeAlD
Bosutinib—PDGFRB—mammalian vulva—Behcet's disease	0.000551	0.000985	CbGeAlD
Bosutinib—MAP2K1—brain—Behcet's disease	0.000541	0.000968	CbGeAlD
Bosutinib—STK35—brain—Behcet's disease	0.000541	0.000968	CbGeAlD
Bosutinib—EPHA2—nervous system—Behcet's disease	0.000541	0.000968	CbGeAlD
Bosutinib—FYN—nervous system—Behcet's disease	0.00054	0.000966	CbGeAlD
Bosutinib—ABL1—skin of body—Behcet's disease	0.000538	0.000962	CbGeAlD
Bosutinib—CSK—brain—Behcet's disease	0.000538	0.000962	CbGeAlD
Bosutinib—CSNK1A1—brain—Behcet's disease	0.000534	0.000955	CbGeAlD
Bosutinib—CLK1—brain—Behcet's disease	0.000531	0.000949	CbGeAlD
Bosutinib—HCK—brain—Behcet's disease	0.000531	0.000949	CbGeAlD
Bosutinib—MAP3K3—nervous system—Behcet's disease	0.000528	0.000944	CbGeAlD
Bosutinib—MAP4K5—nervous system—Behcet's disease	0.000528	0.000944	CbGeAlD
Bosutinib—ABL2—brain—Behcet's disease	0.000527	0.000943	CbGeAlD
Bosutinib—PDGFRB—cardiac atrium—Behcet's disease	0.000527	0.000943	CbGeAlD
Bosutinib—MAP2K5—midbrain—Behcet's disease	0.000525	0.000939	CbGeAlD
Bosutinib—EPHA2—central nervous system—Behcet's disease	0.000521	0.000932	CbGeAlD
Bosutinib—CAMK2G—brain—Behcet's disease	0.000521	0.000932	CbGeAlD
Bosutinib—BMP2K—brain—Behcet's disease	0.000521	0.000932	CbGeAlD
Bosutinib—FYN—central nervous system—Behcet's disease	0.00052	0.00093	CbGeAlD
Bosutinib—LRRK2—brain—Behcet's disease	0.000516	0.000923	CbGeAlD
Bosutinib—EGFR—brain—Behcet's disease	0.000515	0.000921	CbGeAlD
Bosutinib—CSF1R—midbrain—Behcet's disease	0.000512	0.000916	CbGeAlD
Bosutinib—MAP2K5—spinal cord—Behcet's disease	0.000512	0.000916	CbGeAlD
Bosutinib—MAP3K3—central nervous system—Behcet's disease	0.000508	0.000909	CbGeAlD
Bosutinib—MAP4K5—central nervous system—Behcet's disease	0.000508	0.000909	CbGeAlD
Bosutinib—PTK2B—brain—Behcet's disease	0.000503	0.0009	CbGeAlD
Bosutinib—CSF1R—spinal cord—Behcet's disease	0.0005	0.000894	CbGeAlD
Bosutinib—PDGFRB—medulla oblongata—Behcet's disease	0.000497	0.000889	CbGeAlD
Bosutinib—CSNK1E—brain—Behcet's disease	0.000495	0.000885	CbGeAlD
Bosutinib—ABL1—mammalian vulva—Behcet's disease	0.000491	0.000878	CbGeAlD
Bosutinib—YES1—nervous system—Behcet's disease	0.000488	0.000872	CbGeAlD
Bosutinib—SIK1—brain—Behcet's disease	0.000487	0.000872	CbGeAlD
Bosutinib—IRAK4—brain—Behcet's disease	0.000487	0.000872	CbGeAlD
Bosutinib—STK10—nervous system—Behcet's disease	0.000483	0.000864	CbGeAlD
Bosutinib—EPHA4—brain—Behcet's disease	0.000482	0.000863	CbGeAlD
Bosutinib—TAOK3—nervous system—Behcet's disease	0.000481	0.000861	CbGeAlD
Bosutinib—ERBB3—brain—Behcet's disease	0.000478	0.000854	CbGeAlD
Bosutinib—ULK3—brain—Behcet's disease	0.000477	0.000852	CbGeAlD
Bosutinib—MAP2K2—brain—Behcet's disease	0.000477	0.000852	CbGeAlD
Bosutinib—MAP3K2—brain—Behcet's disease	0.000473	0.000846	CbGeAlD
Bosutinib—ABL1—cardiac atrium—Behcet's disease	0.00047	0.000841	CbGeAlD
Bosutinib—YES1—central nervous system—Behcet's disease	0.000469	0.00084	CbGeAlD
Bosutinib—SRC—nervous system—Behcet's disease	0.000469	0.000839	CbGeAlD
Bosutinib—MAP3K7—brain—Behcet's disease	0.000469	0.000838	CbGeAlD
Bosutinib—STK10—central nervous system—Behcet's disease	0.000465	0.000832	CbGeAlD
Bosutinib—TAOK3—central nervous system—Behcet's disease	0.000463	0.000829	CbGeAlD
Bosutinib—PTK2—brain—Behcet's disease	0.000463	0.000829	CbGeAlD
Bosutinib—TBK1—brain—Behcet's disease	0.000463	0.000829	CbGeAlD
Bosutinib—PDGFRB—midbrain—Behcet's disease	0.000454	0.000813	CbGeAlD
Bosutinib—IRAK1—brain—Behcet's disease	0.000454	0.000812	CbGeAlD
Bosutinib—SRC—central nervous system—Behcet's disease	0.000452	0.000808	CbGeAlD
Bosutinib—RPS6KB1—brain—Behcet's disease	0.000446	0.000797	CbGeAlD
Bosutinib—PDGFRB—spinal cord—Behcet's disease	0.000443	0.000793	CbGeAlD
Bosutinib—ABL1—medulla oblongata—Behcet's disease	0.000443	0.000792	CbGeAlD
Bosutinib—FGR—brain—Behcet's disease	0.000443	0.000792	CbGeAlD
Bosutinib—AXL—brain—Behcet's disease	0.000441	0.000789	CbGeAlD
Bosutinib—MAP2K5—nervous system—Behcet's disease	0.000432	0.000772	CbGeAlD
Bosutinib—SLK—brain—Behcet's disease	0.000425	0.00076	CbGeAlD
Bosutinib—EPHB4—brain—Behcet's disease	0.000422	0.000754	CbGeAlD
Bosutinib—CSF1R—nervous system—Behcet's disease	0.000421	0.000753	CbGeAlD
Bosutinib—MAP2K5—central nervous system—Behcet's disease	0.000415	0.000743	CbGeAlD
Bosutinib—EPHA2—brain—Behcet's disease	0.000414	0.00074	CbGeAlD
Bosutinib—FYN—brain—Behcet's disease	0.000413	0.000739	CbGeAlD
Bosutinib—CSF1R—central nervous system—Behcet's disease	0.000405	0.000725	CbGeAlD
Bosutinib—ABL1—midbrain—Behcet's disease	0.000405	0.000724	CbGeAlD
Bosutinib—MAP3K3—brain—Behcet's disease	0.000404	0.000722	CbGeAlD
Bosutinib—MAP4K5—brain—Behcet's disease	0.000404	0.000722	CbGeAlD
Bosutinib—ABL1—spinal cord—Behcet's disease	0.000395	0.000707	CbGeAlD
Bosutinib—PDGFRB—nervous system—Behcet's disease	0.000373	0.000668	CbGeAlD
Bosutinib—YES1—brain—Behcet's disease	0.000373	0.000667	CbGeAlD
Bosutinib—STK10—brain—Behcet's disease	0.000369	0.000661	CbGeAlD
Bosutinib—TAOK3—brain—Behcet's disease	0.000368	0.000658	CbGeAlD
Bosutinib—ABCB1—blood vessel—Behcet's disease	0.000361	0.000646	CbGeAlD
Bosutinib—PDGFRB—central nervous system—Behcet's disease	0.00036	0.000643	CbGeAlD
Bosutinib—SRC—brain—Behcet's disease	0.000359	0.000641	CbGeAlD
Bosutinib—ABL1—nervous system—Behcet's disease	0.000333	0.000595	CbGeAlD
Bosutinib—MAP2K5—brain—Behcet's disease	0.00033	0.00059	CbGeAlD
Bosutinib—CSF1R—brain—Behcet's disease	0.000322	0.000576	CbGeAlD
Bosutinib—ABL1—central nervous system—Behcet's disease	0.00032	0.000573	CbGeAlD
Bosutinib—PDGFRB—brain—Behcet's disease	0.000285	0.000511	CbGeAlD
Bosutinib—ABL1—brain—Behcet's disease	0.000254	0.000455	CbGeAlD
Bosutinib—ABCB1—retina—Behcet's disease	0.000191	0.000341	CbGeAlD
Bosutinib—ABCB1—mammalian vulva—Behcet's disease	0.000153	0.000273	CbGeAlD
Bosutinib—CYP3A4—nervous system—Behcet's disease	0.000146	0.000262	CbGeAlD
Bosutinib—CYP3A4—central nervous system—Behcet's disease	0.000141	0.000252	CbGeAlD
Bosutinib—ABCB1—medulla oblongata—Behcet's disease	0.000138	0.000246	CbGeAlD
Bosutinib—ABCB1—midbrain—Behcet's disease	0.000126	0.000225	CbGeAlD
Bosutinib—ABCB1—spinal cord—Behcet's disease	0.000123	0.00022	CbGeAlD
Bosutinib—ABCB1—nervous system—Behcet's disease	0.000104	0.000185	CbGeAlD
Bosutinib—ABCB1—central nervous system—Behcet's disease	9.97e-05	0.000178	CbGeAlD
Bosutinib—ABCB1—brain—Behcet's disease	7.91e-05	0.000142	CbGeAlD
Bosutinib—BCR—Signaling Pathways—NOS3—Behcet's disease	6.94e-05	0.000157	CbGpPWpGaD
Bosutinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	6.89e-05	0.000156	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CTLA4—Behcet's disease	6.89e-05	0.000156	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—ICAM1—Behcet's disease	6.86e-05	0.000156	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—HLA-B—Behcet's disease	6.85e-05	0.000155	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—HLA-B—Behcet's disease	6.83e-05	0.000155	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—APOB—Behcet's disease	6.82e-05	0.000155	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—APOA1—Behcet's disease	6.81e-05	0.000154	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—ICAM1—Behcet's disease	6.76e-05	0.000153	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—CXCL8—Behcet's disease	6.73e-05	0.000153	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CTLA4—Behcet's disease	6.72e-05	0.000153	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—APOA1—Behcet's disease	6.68e-05	0.000152	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—APOA1—Behcet's disease	6.68e-05	0.000152	CbGpPWpGaD
Bosutinib—ERBB4—Disease—APOA1—Behcet's disease	6.66e-05	0.000151	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	6.66e-05	0.000151	CbGpPWpGaD
Bosutinib—PTK2—Immune System—HLA-B—Behcet's disease	6.62e-05	0.00015	CbGpPWpGaD
Bosutinib—BLK—Immune System—ICAM1—Behcet's disease	6.6e-05	0.00015	CbGpPWpGaD
Bosutinib—LYN—Immune System—CTLA4—Behcet's disease	6.58e-05	0.000149	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—HLA-B—Behcet's disease	6.58e-05	0.000149	CbGpPWpGaD
Bosutinib—FGR—Immune System—ICAM1—Behcet's disease	6.57e-05	0.000149	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CTLA4—Behcet's disease	6.55e-05	0.000149	CbGpPWpGaD
Bosutinib—YES1—Immune System—HLA-B—Behcet's disease	6.53e-05	0.000148	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—ICAM1—Behcet's disease	6.52e-05	0.000148	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—APOA1—Behcet's disease	6.51e-05	0.000148	CbGpPWpGaD
Bosutinib—FYN—Immune System—CTLA4—Behcet's disease	6.48e-05	0.000147	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—APOA1—Behcet's disease	6.45e-05	0.000146	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CTLA4—Behcet's disease	6.45e-05	0.000146	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—CXCL8—Behcet's disease	6.42e-05	0.000146	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—ICAM1—Behcet's disease	6.42e-05	0.000146	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—SERPINE1—Behcet's disease	6.35e-05	0.000144	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—SERPINE1—Behcet's disease	6.3e-05	0.000143	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—SERPINE1—Behcet's disease	6.27e-05	0.000142	CbGpPWpGaD
Bosutinib—ROCK1—Developmental Biology—TNF—Behcet's disease	6.23e-05	0.000141	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—SERPINE1—Behcet's disease	6.21e-05	0.000141	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—HLA-B—Behcet's disease	6.19e-05	0.00014	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—CXCL8—Behcet's disease	6.16e-05	0.00014	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCR1—Behcet's disease	6.13e-05	0.000139	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—SERPINE1—Behcet's disease	6.12e-05	0.000139	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—NOS3—Behcet's disease	6.07e-05	0.000138	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—HLA-B—Behcet's disease	6.07e-05	0.000138	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—ICAM1—Behcet's disease	6.04e-05	0.000137	CbGpPWpGaD
Bosutinib—LYN—Hemostasis—NOS3—Behcet's disease	6.02e-05	0.000137	CbGpPWpGaD
Bosutinib—ABL1—Hemostasis—NOS3—Behcet's disease	5.99e-05	0.000136	CbGpPWpGaD
Bosutinib—FYN—Hemostasis—NOS3—Behcet's disease	5.92e-05	0.000134	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCR1—Behcet's disease	5.91e-05	0.000134	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—APOB—Behcet's disease	5.9e-05	0.000134	CbGpPWpGaD
Bosutinib—SRC—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	5.88e-05	0.000133	CbGpPWpGaD
Bosutinib—ERBB3—Disease—APOA1—Behcet's disease	5.87e-05	0.000133	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—NOS3—Behcet's disease	5.84e-05	0.000133	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—HLA-B—Behcet's disease	5.83e-05	0.000132	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—HLA-B—Behcet's disease	5.83e-05	0.000132	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—APOB—Behcet's disease	5.81e-05	0.000132	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—APOA1—Behcet's disease	5.76e-05	0.000131	CbGpPWpGaD
Bosutinib—HCK—Disease—SERPINE1—Behcet's disease	5.61e-05	0.000127	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CTLA4—Behcet's disease	5.6e-05	0.000127	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—APOB—Behcet's disease	5.6e-05	0.000127	CbGpPWpGaD
Bosutinib—ROCK1—GPCR downstream signaling—CXCL8—Behcet's disease	5.55e-05	0.000126	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—ICAM1—Behcet's disease	5.55e-05	0.000126	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—SERPINE1—Behcet's disease	5.4e-05	0.000123	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—APOA1—Behcet's disease	5.4e-05	0.000122	CbGpPWpGaD
Bosutinib—LCK—Immune System—CTLA4—Behcet's disease	5.4e-05	0.000122	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—APOB—Behcet's disease	5.39e-05	0.000122	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	5.39e-05	0.000122	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—CXCL8—Behcet's disease	5.38e-05	0.000122	CbGpPWpGaD
Bosutinib—PTK2—Immune System—ICAM1—Behcet's disease	5.38e-05	0.000122	CbGpPWpGaD
Bosutinib—HCK—Disease—NOS3—Behcet's disease	5.36e-05	0.000122	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—ICAM1—Behcet's disease	5.35e-05	0.000121	CbGpPWpGaD
Bosutinib—YES1—Immune System—ICAM1—Behcet's disease	5.31e-05	0.00012	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—SERPINE1—Behcet's disease	5.3e-05	0.00012	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—SERPINE1—Behcet's disease	5.3e-05	0.00012	CbGpPWpGaD
Bosutinib—ERBB4—Disease—SERPINE1—Behcet's disease	5.29e-05	0.00012	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR1—Behcet's disease	5.23e-05	0.000119	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—APOB—Behcet's disease	5.2e-05	0.000118	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—SERPINE1—Behcet's disease	5.17e-05	0.000117	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—NOS3—Behcet's disease	5.16e-05	0.000117	CbGpPWpGaD
Bosutinib—PTK2—Developmental Biology—TNF—Behcet's disease	5.15e-05	0.000117	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—SERPINE1—Behcet's disease	5.12e-05	0.000116	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—HLA-B—Behcet's disease	5.1e-05	0.000116	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—APOB—Behcet's disease	5.09e-05	0.000115	CbGpPWpGaD
Bosutinib—YES1—Developmental Biology—TNF—Behcet's disease	5.08e-05	0.000115	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—NOS3—Behcet's disease	5.06e-05	0.000115	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—NOS3—Behcet's disease	5.06e-05	0.000115	CbGpPWpGaD
Bosutinib—ERBB4—Disease—NOS3—Behcet's disease	5.05e-05	0.000115	CbGpPWpGaD
Bosutinib—ROCK1—Signaling by GPCR—CXCL8—Behcet's disease	5.04e-05	0.000114	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—ICAM1—Behcet's disease	5.03e-05	0.000114	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—HLA-B—Behcet's disease	4.97e-05	0.000113	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—APOB—Behcet's disease	4.96e-05	0.000113	CbGpPWpGaD
Bosutinib—LCK—Hemostasis—NOS3—Behcet's disease	4.93e-05	0.000112	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—NOS3—Behcet's disease	4.89e-05	0.000111	CbGpPWpGaD
Bosutinib—LYN—Immune System—HLA-B—Behcet's disease	4.87e-05	0.00011	CbGpPWpGaD
Bosutinib—ABL1—Immune System—HLA-B—Behcet's disease	4.85e-05	0.00011	CbGpPWpGaD
Bosutinib—FYN—Immune System—HLA-B—Behcet's disease	4.79e-05	0.000109	CbGpPWpGaD
Bosutinib—FYN—Disease—APOB—Behcet's disease	4.78e-05	0.000109	CbGpPWpGaD
Bosutinib—SRC—Immune System—CTLA4—Behcet's disease	4.78e-05	0.000108	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—HLA-B—Behcet's disease	4.77e-05	0.000108	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—APOB—Behcet's disease	4.76e-05	0.000108	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—ICAM1—Behcet's disease	4.74e-05	0.000107	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—ICAM1—Behcet's disease	4.73e-05	0.000107	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—APOA1—Behcet's disease	4.67e-05	0.000106	CbGpPWpGaD
Bosutinib—ERBB3—Disease—SERPINE1—Behcet's disease	4.66e-05	0.000106	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—APOB—Behcet's disease	4.63e-05	0.000105	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—APOA1—Behcet's disease	4.6e-05	0.000104	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—CXCL8—Behcet's disease	4.58e-05	0.000104	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—SERPINE1—Behcet's disease	4.57e-05	0.000104	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—APOB—Behcet's disease	4.56e-05	0.000104	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—CXCL8—Behcet's disease	4.49e-05	0.000102	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—CXCL8—Behcet's disease	4.49e-05	0.000102	CbGpPWpGaD
Bosutinib—ERBB3—Disease—NOS3—Behcet's disease	4.45e-05	0.000101	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—APOA1—Behcet's disease	4.43e-05	0.0001	CbGpPWpGaD
Bosutinib—SRC—Hemostasis—NOS3—Behcet's disease	4.37e-05	9.9e-05	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—CXCL8—Behcet's disease	4.34e-05	9.84e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—APOB—Behcet's disease	4.33e-05	9.82e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—SERPINE1—Behcet's disease	4.28e-05	9.72e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—APOA1—Behcet's disease	4.27e-05	9.68e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	4.27e-05	9.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—HLA-B—Behcet's disease	4.14e-05	9.39e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—ICAM1—Behcet's disease	4.14e-05	9.39e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—APOB—Behcet's disease	4.13e-05	9.37e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—APOA1—Behcet's disease	4.11e-05	9.33e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—NOS3—Behcet's disease	4.09e-05	9.28e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—APOB—Behcet's disease	4.08e-05	9.24e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—ICAM1—Behcet's disease	4.04e-05	9.17e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—APOA1—Behcet's disease	4.02e-05	9.13e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—HLA-B—Behcet's disease	3.99e-05	9.05e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—APOB—Behcet's disease	3.98e-05	9.03e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Developmental Biology—TNF—Behcet's disease	3.96e-05	8.99e-05	CbGpPWpGaD
Bosutinib—LYN—Immune System—ICAM1—Behcet's disease	3.96e-05	8.97e-05	CbGpPWpGaD
Bosutinib—ABL1—Immune System—ICAM1—Behcet's disease	3.94e-05	8.93e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—APOA1—Behcet's disease	3.93e-05	8.91e-05	CbGpPWpGaD
Bosutinib—FYN—Immune System—ICAM1—Behcet's disease	3.89e-05	8.83e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—ICAM1—Behcet's disease	3.87e-05	8.79e-05	CbGpPWpGaD
Bosutinib—LYN—Developmental Biology—TNF—Behcet's disease	3.79e-05	8.59e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—APOA1—Behcet's disease	3.78e-05	8.58e-05	CbGpPWpGaD
Bosutinib—ABL1—Developmental Biology—TNF—Behcet's disease	3.77e-05	8.55e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—APOA1—Behcet's disease	3.76e-05	8.54e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	3.73e-05	8.46e-05	CbGpPWpGaD
Bosutinib—FYN—Developmental Biology—TNF—Behcet's disease	3.73e-05	8.46e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Developmental Biology—TNF—Behcet's disease	3.71e-05	8.41e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—SERPINE1—Behcet's disease	3.7e-05	8.4e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—APOA1—Behcet's disease	3.66e-05	8.3e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—SERPINE1—Behcet's disease	3.65e-05	8.28e-05	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—CXCL8—Behcet's disease	3.63e-05	8.23e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—APOA1—Behcet's disease	3.61e-05	8.19e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—APOB—Behcet's disease	3.56e-05	8.08e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—NOS3—Behcet's disease	3.54e-05	8.02e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—HLA-B—Behcet's disease	3.53e-05	8.01e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—APOB—Behcet's disease	3.53e-05	8e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—SERPINE1—Behcet's disease	3.52e-05	7.97e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—NOS3—Behcet's disease	3.48e-05	7.9e-05	CbGpPWpGaD
Bosutinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	3.48e-05	7.89e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	3.48e-05	7.88e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—APOA1—Behcet's disease	3.42e-05	7.77e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOB—Behcet's disease	3.4e-05	7.72e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—SERPINE1—Behcet's disease	3.39e-05	7.68e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	3.39e-05	7.68e-05	CbGpPWpGaD
Bosutinib—EGFR—Immune System—ICAM1—Behcet's disease	3.36e-05	7.63e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—NOS3—Behcet's disease	3.36e-05	7.61e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOB—Behcet's disease	3.35e-05	7.6e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOB—Behcet's disease	3.33e-05	7.56e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—APOA1—Behcet's disease	3.27e-05	7.42e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—SERPINE1—Behcet's disease	3.26e-05	7.41e-05	CbGpPWpGaD
Bosutinib—LCK—Immune System—ICAM1—Behcet's disease	3.24e-05	7.36e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	3.23e-05	7.33e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—NOS3—Behcet's disease	3.23e-05	7.33e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—APOA1—Behcet's disease	3.22e-05	7.31e-05	CbGpPWpGaD
Bosutinib—EGFR—Developmental Biology—TNF—Behcet's disease	3.22e-05	7.31e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—CXCL8—Behcet's disease	3.21e-05	7.27e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—SERPINE1—Behcet's disease	3.19e-05	7.24e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—APOA1—Behcet's disease	3.15e-05	7.15e-05	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—CXCL8—Behcet's disease	3.14e-05	7.11e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—NOS3—Behcet's disease	3.12e-05	7.07e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—SERPINE1—Behcet's disease	3.12e-05	7.07e-05	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—CXCL8—Behcet's disease	3.09e-05	7.01e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—NOS3—Behcet's disease	3.05e-05	6.92e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—SERPINE1—Behcet's disease	3e-05	6.81e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—CXCL8—Behcet's disease	3e-05	6.8e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—SERPINE1—Behcet's disease	2.99e-05	6.78e-05	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—CXCL8—Behcet's disease	2.98e-05	6.75e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—NOS3—Behcet's disease	2.98e-05	6.75e-05	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.95e-05	6.69e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—SERPINE1—Behcet's disease	2.91e-05	6.59e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOB—Behcet's disease	2.89e-05	6.56e-05	CbGpPWpGaD
Bosutinib—SRC—Immune System—ICAM1—Behcet's disease	2.87e-05	6.51e-05	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—CXCL8—Behcet's disease	2.87e-05	6.51e-05	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	2.87e-05	6.51e-05	CbGpPWpGaD
Bosutinib—FYN—Disease—NOS3—Behcet's disease	2.87e-05	6.51e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—SERPINE1—Behcet's disease	2.87e-05	6.5e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—NOS3—Behcet's disease	2.85e-05	6.47e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—APOA1—Behcet's disease	2.82e-05	6.39e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—APOA1—Behcet's disease	2.79e-05	6.33e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOB—Behcet's disease	2.79e-05	6.33e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—NOS3—Behcet's disease	2.77e-05	6.29e-05	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—CXCL8—Behcet's disease	2.76e-05	6.27e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	2.75e-05	6.24e-05	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—TNF—Behcet's disease	2.75e-05	6.23e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—NOS3—Behcet's disease	2.74e-05	6.21e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—SERPINE1—Behcet's disease	2.72e-05	6.17e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—APOA1—Behcet's disease	2.69e-05	6.11e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—APOA1—Behcet's disease	2.65e-05	6.01e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—APOA1—Behcet's disease	2.64e-05	5.98e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—CXCL8—Behcet's disease	2.61e-05	5.91e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—SERPINE1—Behcet's disease	2.6e-05	5.89e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—NOS3—Behcet's disease	2.6e-05	5.89e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—SERPINE1—Behcet's disease	2.56e-05	5.81e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—SERPINE1—Behcet's disease	2.5e-05	5.67e-05	CbGpPWpGaD
Bosutinib—EGFR—Disease—NOS3—Behcet's disease	2.48e-05	5.62e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOB—Behcet's disease	2.47e-05	5.6e-05	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CXCL8—Behcet's disease	2.46e-05	5.58e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—NOS3—Behcet's disease	2.44e-05	5.54e-05	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CXCL8—Behcet's disease	2.43e-05	5.51e-05	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS3—Behcet's disease	2.39e-05	5.42e-05	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CXCL8—Behcet's disease	2.3e-05	5.22e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—APOA1—Behcet's disease	2.29e-05	5.19e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—SERPINE1—Behcet's disease	2.24e-05	5.07e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—SERPINE1—Behcet's disease	2.21e-05	5.02e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—APOA1—Behcet's disease	2.21e-05	5.01e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	2.18e-05	4.95e-05	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CXCL8—Behcet's disease	2.17e-05	4.92e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—SERPINE1—Behcet's disease	2.14e-05	4.85e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—Behcet's disease	2.14e-05	4.84e-05	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—Behcet's disease	2.11e-05	4.8e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—SERPINE1—Behcet's disease	2.1e-05	4.77e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—SERPINE1—Behcet's disease	2.09e-05	4.75e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	2.08e-05	4.73e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—Behcet's disease	2.04e-05	4.63e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—Behcet's disease	2.01e-05	4.56e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—Behcet's disease	2e-05	4.53e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—APOA1—Behcet's disease	1.95e-05	4.43e-05	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CXCL8—Behcet's disease	1.89e-05	4.3e-05	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	1.85e-05	4.19e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—SERPINE1—Behcet's disease	1.82e-05	4.12e-05	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CXCL8—Behcet's disease	1.81e-05	4.1e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—CAT—Behcet's disease	1.8e-05	4.08e-05	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CXCL8—Behcet's disease	1.78e-05	4.04e-05	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CXCL8—Behcet's disease	1.77e-05	4.02e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—SERPINE1—Behcet's disease	1.75e-05	3.97e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOB—Behcet's disease	1.75e-05	3.96e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—Behcet's disease	1.74e-05	3.94e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—Behcet's disease	1.67e-05	3.79e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—SERPINE1—Behcet's disease	1.55e-05	3.52e-05	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CXCL8—Behcet's disease	1.54e-05	3.49e-05	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CXCL8—Behcet's disease	1.48e-05	3.36e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—Behcet's disease	1.48e-05	3.36e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—APOA1—Behcet's disease	1.38e-05	3.14e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CXCL8—Behcet's disease	1.31e-05	2.98e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—CAT—Behcet's disease	1.11e-05	2.51e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOB—Behcet's disease	1.08e-05	2.44e-05	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—Behcet's disease	1.05e-05	2.38e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—APOA1—Behcet's disease	8.52e-06	1.93e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—Behcet's disease	6.45e-06	1.46e-05	CbGpPWpGaD
